Investigating the etiology of acute febrile illness: a prospective clinic-based study in Uganda.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
16 Jun 2023
Historique:
received: 25 12 2022
accepted: 17 05 2023
medline: 19 6 2023
pubmed: 17 6 2023
entrez: 16 6 2023
Statut: epublish

Résumé

Historically, malaria has been the predominant cause of acute febrile illness (AFI) in sub-Saharan Africa. However, during the last two decades, malaria incidence has declined due to concerted public health control efforts, including the widespread use of rapid diagnostic tests leading to increased recognition of non-malarial AFI etiologies. Our understanding of non-malarial AFI is limited due to lack of laboratory diagnostic capacity. We aimed to determine the etiology of AFI in three distinct regions of Uganda. A prospective clinic-based study that enrolled participants from April 2011 to January 2013 using standard diagnostic tests. Participant recruitment was from St. Paul's Health Centre (HC) IV, Ndejje HC IV, and Adumi HC IV in the western, central and northern regions, which differ by climate, environment, and population density. A Pearson's chi-square test was used to evaluate categorical variables, while a two-sample t-test and Krukalis-Wallis test were used for continuous variables. Of the 1281 participants, 450 (35.1%), 382 (29.8%), and 449 (35.1%) were recruited from the western, central, and northern regions, respectively. The median age (range) was 18 (2-93) years; 717 (56%) of the participants were female. At least one AFI pathogen was identified in 1054 (82.3%) participants; one or more non-malarial AFI pathogens were identified in 894 (69.8%) participants. The non-malarial AFI pathogens identified were chikungunya virus, 716 (55.9%); Spotted Fever Group rickettsia (SFGR), 336 (26.2%) and Typhus Group rickettsia (TGR), 97 (7.6%); typhoid fever (TF), 74 (5.8%); West Nile virus, 7 (0.5%); dengue virus, 10 (0.8%) and leptospirosis, 2 (0.2%) cases. No cases of brucellosis were identified. Malaria was diagnosed either concurrently or alone in 404 (31.5%) and 160 (12.5%) participants, respectively. In 227 (17.7%) participants, no cause of infection was identified. There were statistically significant differences in the occurrence and distribution of TF, TGR and SFGR, with TF and TGR observed more frequently in the western region (p = 0.001; p < 0.001) while SFGR in the northern region (p < 0.001). Malaria, arboviral infections, and rickettsioses are major causes of AFI in Uganda. Development of a Multiplexed Point-of-Care test would help identify the etiology of non-malarial AFI in regions with high AFI rates.

Sections du résumé

BACKGROUND BACKGROUND
Historically, malaria has been the predominant cause of acute febrile illness (AFI) in sub-Saharan Africa. However, during the last two decades, malaria incidence has declined due to concerted public health control efforts, including the widespread use of rapid diagnostic tests leading to increased recognition of non-malarial AFI etiologies. Our understanding of non-malarial AFI is limited due to lack of laboratory diagnostic capacity. We aimed to determine the etiology of AFI in three distinct regions of Uganda.
METHODS METHODS
A prospective clinic-based study that enrolled participants from April 2011 to January 2013 using standard diagnostic tests. Participant recruitment was from St. Paul's Health Centre (HC) IV, Ndejje HC IV, and Adumi HC IV in the western, central and northern regions, which differ by climate, environment, and population density. A Pearson's chi-square test was used to evaluate categorical variables, while a two-sample t-test and Krukalis-Wallis test were used for continuous variables.
RESULTS RESULTS
Of the 1281 participants, 450 (35.1%), 382 (29.8%), and 449 (35.1%) were recruited from the western, central, and northern regions, respectively. The median age (range) was 18 (2-93) years; 717 (56%) of the participants were female. At least one AFI pathogen was identified in 1054 (82.3%) participants; one or more non-malarial AFI pathogens were identified in 894 (69.8%) participants. The non-malarial AFI pathogens identified were chikungunya virus, 716 (55.9%); Spotted Fever Group rickettsia (SFGR), 336 (26.2%) and Typhus Group rickettsia (TGR), 97 (7.6%); typhoid fever (TF), 74 (5.8%); West Nile virus, 7 (0.5%); dengue virus, 10 (0.8%) and leptospirosis, 2 (0.2%) cases. No cases of brucellosis were identified. Malaria was diagnosed either concurrently or alone in 404 (31.5%) and 160 (12.5%) participants, respectively. In 227 (17.7%) participants, no cause of infection was identified. There were statistically significant differences in the occurrence and distribution of TF, TGR and SFGR, with TF and TGR observed more frequently in the western region (p = 0.001; p < 0.001) while SFGR in the northern region (p < 0.001).
CONCLUSION CONCLUSIONS
Malaria, arboviral infections, and rickettsioses are major causes of AFI in Uganda. Development of a Multiplexed Point-of-Care test would help identify the etiology of non-malarial AFI in regions with high AFI rates.

Identifiants

pubmed: 37328808
doi: 10.1186/s12879-023-08335-4
pii: 10.1186/s12879-023-08335-4
pmc: PMC10276394
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

411

Subventions

Organisme : CDC HHS
ID : CK08-004
Pays : United States
Organisme : CDC HHS
ID : CK08-004
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Trans R Soc Trop Med Hyg. 1962 Nov;56:496-503
pubmed: 13998488
Am J Trop Med Hyg. 2015 Jul;93(1):178-80
pubmed: 25918207
Antibodies (Basel). 2023 Feb 24;12(1):
pubmed: 36975365
Lancet Planet Health. 2020 Sep;4(9):e416-e423
pubmed: 32918887
Environ Int. 2016 Jan;86:14-23
pubmed: 26479830
PLoS One. 2019 Apr 22;14(4):e0214650
pubmed: 31009473
Virology. 1998 Dec 5;252(1):258-68
pubmed: 9875334
PLoS One. 2015 Jun 30;10(6):e0127962
pubmed: 26126200
Afr Health Sci. 2018 Mar;18(1):22-28
pubmed: 29977253
BMC Infect Dis. 2020 Apr 7;20(1):270
pubmed: 32264829
PLoS Negl Trop Dis. 2013 Jul 18;7(7):e2324
pubmed: 23875053
Emerg Infect Dis. 2019 Feb;25(2):299-303
pubmed: 30666931
Emerg Infect Dis. 2014 Dec;20(12):2129-32
pubmed: 25418184
PLoS One. 2010 Jul 29;5(7):e11872
pubmed: 20686697
PLoS Med. 2016 Nov 8;13(11):e1002167
pubmed: 27824885
Lancet Infect Dis. 2013 Dec;13(12):1057-98
pubmed: 24252483
Open Forum Infect Dis. 2019 Jan 03;6(3):ofz001
pubmed: 31660384
Geospat Health. 2021 Jan 07;15(2):
pubmed: 33461278
Malar J. 2017 Jan 3;16(1):4
pubmed: 28049475
Am J Trop Med Hyg. 2012 Dec;87(6):1112-5
pubmed: 23109371
Am J Trop Med Hyg. 2019 Mar;100(3):659-671
pubmed: 30675833
PLoS Negl Trop Dis. 2012;6(6):e1649
pubmed: 22720097
Emerg Infect Dis. 1997 Jan-Mar;3(1):77
pubmed: 9126450
Ticks Tick Borne Dis. 2013 Dec;4(6):506-12
pubmed: 24331642
Parasit Vectors. 2013 Dec 05;6:340
pubmed: 24304974
Infect Dis Poverty. 2022 Jul 23;11(1):83
pubmed: 35870946
Malar J. 2019 Feb 21;18(1):44
pubmed: 30791906
Trop Dis Travel Med Vaccines. 2019 Nov 29;5:21
pubmed: 31798935
Am J Trop Med Hyg. 2010 Jul;83(1):61-8
pubmed: 20595479
Emerg Infect Dis. 2013 Feb;19(2):317-20
pubmed: 23347529
PLoS One. 2018 May 1;13(5):e0196799
pubmed: 29715287
J Med Microbiol. 2003 Oct;52(Pt 10):897-901
pubmed: 12972585
BMC Infect Dis. 2016 Oct 28;16(1):612
pubmed: 27793106
J Pediatric Infect Dis Soc. 2016 Jun;5(2):190-205
pubmed: 27059657
Sci Rep. 2018 Oct 18;8(1):15465
pubmed: 30337685
Am J Trop Med Hyg. 1966 Jul;15(4):523-30
pubmed: 4957422
Trans R Soc Trop Med Hyg. 1972;66(5):783-8
pubmed: 4647650
Annu Rev Biomed Eng. 2008;10:107-44
pubmed: 18358075
Trans R Soc Trop Med Hyg. 1958 May;52(3):253-7
pubmed: 13556869
J Infect Public Health. 2016 Jan-Feb;9(1):52-9
pubmed: 26256113
Trans R Soc Trop Med Hyg. 1989 Nov-Dec;83(6):851-4
pubmed: 2559514
Am J Trop Med Hyg. 2015 Aug;93(2):276-280
pubmed: 26055736
Ann N Y Acad Sci. 2008 Dec;1149:309-11
pubmed: 19120236
Trans R Soc Trop Med Hyg. 1971;65(2):152-68
pubmed: 4997499
J Med Entomol. 2023 Jan 12;60(1):185-192
pubmed: 36321534
Clin Diagn Lab Immunol. 2003 Nov;10(6):1141-6
pubmed: 14607880
Virusdisease. 2019 Sep;30(3):469-473
pubmed: 31803816
BMC Infect Dis. 2020 Nov 11;20(1):835
pubmed: 33176708
PLoS Negl Trop Dis. 2016 Aug 03;10(8):e0004858
pubmed: 27487398
PLOS Glob Public Health. 2023 May 3;3(5):e0001675
pubmed: 37134083
BMC Infect Dis. 2022 Nov 21;22(1):869
pubmed: 36411415
BMC Public Health. 2020 Dec 14;20(1):1913
pubmed: 33317487
PLoS Negl Trop Dis. 2015 Apr 07;9(4):e0003626
pubmed: 25849718
Malar J. 2016 Jan 28;15:47
pubmed: 26821709
Clin Infect Dis. 2012 Apr;54(8):1091-9
pubmed: 22357703
J Gen Virol. 2007 Sep;88(Pt 9):2363-2377
pubmed: 17698645
PLoS Negl Trop Dis. 2015 Dec 03;9(12):e0004040
pubmed: 26633014
Fam Pract. 2019 Nov 18;36(6):804-807
pubmed: 31738429
Open Forum Infect Dis. 2017 Nov 01;4(4):ofx237
pubmed: 29255733
BMC Public Health. 2015 Sep 15;15:900
pubmed: 26374402
Am J Trop Med Hyg. 2007 Aug;77(2):390-2
pubmed: 17690420

Auteurs

Brian K Kigozi (BK)

Uganda Virus Research Institute, Entebbe, Uganda. brkigozi@infocom.co.ug.
College of Health Sciences, Clinical Epidemiology Unit, Makerere University, Kampala, Uganda. brkigozi@infocom.co.ug.

Grishma A Kharod (GA)

CDC Division of High-Consequence Pathogens and Pathology, Atlanta, USA.

Henry Bukenya (H)

Uganda Virus Research Institute, Entebbe, Uganda.

Sean V Shadomy (SV)

CDC Division of High-Consequence Pathogens and Pathology, Atlanta, USA.

Dana L Haberling (DL)

CDC Division of High-Consequence Pathogens and Pathology, Atlanta, USA.

Robyn A Stoddard (RA)

CDC Division of High-Consequence Pathogens and Pathology, Atlanta, USA.

Renee L Galloway (RL)

CDC Division of High-Consequence Pathogens and Pathology, Atlanta, USA.

Phionah Tushabe (P)

Uganda Virus Research Institute, Entebbe, Uganda.

Annet Nankya (A)

Uganda Virus Research Institute, Entebbe, Uganda.

Thomas Nsibambi (T)

Uganda Virus Research Institute, Entebbe, Uganda.
US Centers for Disease Control and Prevention, Kampala, Uganda.

Edward Katongole Mbidde (EK)

Uganda Virus Research Institute, Entebbe, Uganda.

Julius J Lutwama (JJ)

Uganda Virus Research Institute, Entebbe, Uganda.

Jamie L Perniciaro (JL)

CDC Laboratory Systems, Atlanta, USA.

William L Nicholson (WL)

CDC Rickettsial Zoonoses Branch, Atlanta, USA.

William A Bower (WA)

CDC Division of High-Consequence Pathogens and Pathology, Atlanta, USA.

Josephine Bwogi (J)

Uganda Virus Research Institute, Entebbe, Uganda.

David D Blaney (DD)

CDC Division of High-Consequence Pathogens and Pathology, Atlanta, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH